- Home
- TOVX vs WVVI Comparison
TOVX vs WVVI Comparison
Compare TOVX & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- WVVI
- Stock Information
- Founded
- TOVX 2001
- WVVI 1983
- Country
- TOVX United States
- WVVI United States
- Employees
- TOVX N/A
- WVVI N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- TOVX Health Care
- WVVI Consumer Staples
- Exchange
- TOVX Nasdaq
- WVVI Nasdaq
- Market Cap
- TOVX 3.5M
- WVVI 16.5M
- IPO Year
- TOVX 2006
- WVVI N/A
- Fundamental
- Price
- TOVX $1.14
- WVVI $3.33
- Analyst Decision
- TOVX Strong Buy
- WVVI
- Analyst Count
- TOVX 1
- WVVI 0
- Target Price
- TOVX $6.00
- WVVI N/A
- AVG Volume (30 Days)
- TOVX 96.3K
- WVVI 4.1K
- Earning Date
- TOVX 11-12-2024
- WVVI 11-12-2024
- Dividend Yield
- TOVX N/A
- WVVI N/A
- EPS Growth
- TOVX N/A
- WVVI N/A
- EPS
- TOVX N/A
- WVVI N/A
- Revenue
- TOVX N/A
- WVVI $39,259,016.00
- Revenue This Year
- TOVX N/A
- WVVI N/A
- Revenue Next Year
- TOVX N/A
- WVVI N/A
- P/E Ratio
- TOVX N/A
- WVVI N/A
- Revenue Growth
- TOVX N/A
- WVVI N/A
- 52 Week Low
- TOVX $1.14
- WVVI $3.17
- 52 Week High
- TOVX $17.00
- WVVI $5.40
- Technical
- Relative Strength Index (RSI)
- TOVX 36.15
- WVVI 51.22
- Support Level
- TOVX $1.23
- WVVI $3.17
- Resistance Level
- TOVX $1.21
- WVVI $3.34
- Average True Range (ATR)
- TOVX 0.07
- WVVI 0.07
- MACD
- TOVX 0.01
- WVVI 0.01
- Stochastic Oscillator
- TOVX 0.00
- WVVI 94.12
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.